1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Lymphoma, Malignant: new trials by email Literature Review of Lymphoma, Malignant trials Research Report on Lymphoma, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (PN-152,243)/PN-196,444 - Neoplasms, Thrombocytopenia | Phase 3 | Completed | Pfizer | 180 | 1999-12-01 | 2006-11-09 |
Lymphoma (1) · Multiple Myeloma (1) · Neoplasms (1) · Thrombocytopenia (1)
Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Cytopenia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1)
Pfizer (1)
Argentina (1) · Mexico (1) · United States (1)